In-Hospital Mortality Rare After Percutaneous Coronary Intervention
By Elana Gotkine HealthDay Reporter
MONDAY, April 15, 2024 -- In-hospital mortality is rare after percutaneous coronary intervention (PCI) and is most commonly related to prior cardiovascular condition, according to a study published online March 27 in PLOS ONE.
Francesco Moroni, M.D., from the University of Virginia in Charlottesville, and colleagues analyzed the cause and circumstances of in-hospital mortality in a large, multicenter, statewide cohort. In-hospital deaths after PCI occurring at 39 hospitals between 2012 and 2014 were reviewed using validated methods. Data were included for 1,163 deaths after PCI.
The researchers found that the most common cause of death was left ventricular failure (52 percent of cases). The circumstance of death was most often related to previous acute cardiovascular condition (61 percent of cases). In 20 percent of cases, procedural complications were considered as contributing to mortality. In 89.9 percent of cases, death was rated as not preventable or slightly preventable. Most deaths occurred in intermediate or high-risk patients, but 28.2 percent occurred in low-risk patients, with <5 percent predicted mortality risk. In 30 percent of preventable deaths, PCI was considered rarely appropriate.
"Our data support further research to characterize preventable deaths in order to develop strategies to further enhance procedural safety," the authors write.
Several authors disclosed financial ties to the medical device industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Radial Access for Percutaneous Coronary Intervention Now Dominant Method
THURSDAY, May 16, 2024 -- Use of radial access for percutaneous coronary intervention (PCI) increased 2.8-fold in the United States between 2013 and 2022, according to a study...
CAC Score Predicts MACE in Patients With Stable Chest Pain
THURSDAY, March 14, 2024 -- For people with stable chest pain referred for invasive coronary angiography (ICA), the risk for major adverse cardiovascular events (MACE) is low...
Paclitaxel-Coated Balloon Effective for Coronary In-Stent Restenosis
MONDAY, March 11, 2024 -- A paclitaxel-coated balloon is superior to an uncoated balloon for the composite end point of target lesion failure among patients undergoing coronary...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.